Name | Title | Contact Details |
---|
MAWD Pathology is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
GlobalMed Inc. is a Trenton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
What`s best for each patient drives our business. Through Center for Diagnostic Imaging`s national network, including Insight Imaging, we partner with healthcare providers to do what we do best — manage and deliver high-quality medical imaging (i.e. MRI, PET/CT, etc.) and related services (i.e. injections for pain) to enhance patient care. CDI offers the highest quality of care through a network of outpatient imaging centers and mobile facilities in more than thirty states. Headquartered in Minneapolis, Minnesota; the organization serves more than one million patients a year through a diverse set of customers including healthcare providers, managed care organizations, hospitals, health systems and payors (government and third party). Our local providers and partners are connected through CDI`s large network to other clinical providers and staff across the country. Through CDI`s sophisticated network, our partners access best practices and have the ability to consult with other specialized physicians, when needed, to improve patient care and outcomes. Being a national provider that is locally focused helps CDI provide each patient with the best of both worlds: individualized local patient care and extensive healthcare expertise.
Pro Med Kits is a Davis, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to provide enduring functional benefits for patients. The company is privately held and funded by InterWest Partners, Versant Ventures, DeNovo Ventures, Domain Associates and Technology Partners. Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $9 billion globally.